# Werewolf Therapeutics, Inc.: Form 8-K, filed Feb 13, 2026

- Company: [Werewolf Therapeutics, Inc.](/companies/howl.md) (CIK 1785530)
- Form: 8-K
- Filed: 2026-02-13
- Accepted by EDGAR: Feb 13, 2026, 16:20 ET
- Period: 2026-02-09
- Accession: 0001193125-26-051455
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1785530/000119312526051455/d110809d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785530/000119312526051455/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785530/000119312526051455/d110809d8k.htm

Filed Feb 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-051455. Last ingested by Listed: Nov 14, 2026, 19:15 ET. No prices; not investment advice.
